Cardiovascular Risk Assessment and the Role of Dyslipidemia (2019)

Cardiovascular Risk Assessment and the Role of Dyslipidemia (2019)

Approximately 90% of adult Canadians have at least one major risk factor (dyslipidemia, hypertension, cigarette smoking, sedentary lifestyle, high alcohol intake, obesity, diabetes) for coronary artery disease (CAD).1 Coronary artery disease, also called coronary heart disease (CHD), is caused by atherosclerosis and refers to narrowing of the arteries supplying blood and oxygen to the heart.2 Despite reductions of almost 40% in the age-specific mortality rate due to CAD in Canada over the past several decades, the condition remains a major cause of death and morbidity in the western hemisphere.3 In fact, approximately one in three 40-year-old women has a risk for developing CAD in their lifetime, while a man 40 years of age has a risk of one in two.4

Cardiovascular (CV) risk assessment is recommended as a means for primary healthcare providers to identify patients who would be most likely to benefit from primary prevention therapies such as treatment of dyslipidemia or hypertension.5 It is important to identify individuals at risk as early as possible in order that lifestyle, plus or minus pharmacological treatment, may be started. Therefore, it is important that risk assessment be as accessible as possible.   

This series of three modules has been developed to help participants better understand the pathophysiology of atherosclerosis and CV risk assessment.  The third module in the series provides tips to participants about how to communicate CV risk assessment results effectively and to motivate patients to take action with respect to initiation of lifestyle modification.

Module 1: Cardiovascular Risk Assessment Background

Module 2: A Step-by-Step Approach to Managing Dyslipidemia

Module 3: Communication and Action Plans

Disclosures: The author and reviewers have no conflicts of interest to disclose.

1.50 CEU

Tom Smiley
BScPhm, PharmD, CTE


Michael Boivin

Carlene Oleksyn

(Expires: 22-Mar-2019)